âChaosâ followed ruling on abortion drug access, and providers say more uncertainty lies ahead | CNN
Like on many other days, the last thing Leah Coplon did before she left work Friday was to check a litigation tracker. Coplon, the director of clinical operations for Abortion on Demand, was watching for any updates about legal action on abortion pills. Around 5 p.m., it was quiet. Coplon made a short commute to downtown Portland, Maine, to attend a May Day rally. She had just arrived when she got the news. The 5th US Circuit Court of Appeals had blocked access by telemedicine or mail to mifepristone, one of the pills used in a standard regimen for medication abortion that has been approved by the US Food and Drug Administration for decades. Abortion providers have long been preparing for potential restrictions on telehealth abortion, but whiplash from the court ruling that landed late Friday and another that followed Monday morning challenged even some of the best-laid plans. Providers whom CNN talked to describe the time between the court actions as some of the âcraziestâ and most âchaoticâ days theyâve had. Supreme Court temporarily restores ability to receive abortion drug mifepristone by mail In an appeal Saturday, Danco Laboratories, a maker of the mifepristone pill
Source: For the complete article, please visit the original source link below.
